GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
B

Bausch Health Companies BHC.TO · CAD

Health Care · Toronto Stock Exchange · 🇨🇦 Canada

Compare

11.88

+2.77%

Close of 9 Nov 2026, in CAD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in USD, from our data supplier.

FY2025

Revenue

$10.45bn

FY2016FY2025

Net income

$159.7m

FY2016FY2025

Free cash flow

$974.8m

FY2016FY2025

Shareholders' equity

−$553.0m

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue$10.45bn$9.63bn$8.76bn$8.12bn$8.43bn$8.03bn$8.60bn$8.38bn$8.72bn$9.67bn
Research and development$640.0m$616.0m$604.0m$529.0m$465.0m$452.0m$471.0m$414.0m$366.0m$455.0m
Operating income$1.93bn$1.55bn$963.0m$1.37bn$1.21bn$676.0m−$73.0m−$2.29bn$102.0m−$566.0m
Net income$159.7m−$46.0m−$592.0m−$212.0m−$937.0m−$559.0m−$1.78bn−$4.15bn$2.40bn−$2.41bn
Diluted earnings per share0.43-0.12-1.67-0.58-2.57-1.56-4.96-11.866.79-6.89

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assets$26.32bn$26.52bn$27.35bn$25.69bn$29.20bn$31.20bn$33.86bn$27.45bn$37.50bn$43.53bn
Cash and short-term investments$1.32bn$1.18bn$947.0m$564.0m$582.0m$605.0m$3.24bn$721.0m$720.0m$542.0m
Total liabilities$25.94bn$26.84bn$27.43bn$25.43bn$29.24bn$30.59bn$32.73bn$24.63bn$31.55bn$40.27bn
Debt$21.21bn$21.62bn$22.39bn$20.77bn$22.65bn$25.16bn$25.89bn$24.63bn$25.44bn$29.85bn
Shareholders' equity−$553.0m−$1.28bn−$1.02bn−$692.0m−$106.0m$535.0m$1.06bn$2.73bn$5.85bn$3.15bn
Shares outstanding371m372m355m363m364m359m359m350m354m350m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations$1.38bn$1.60bn$1.03bn−$728.0m$1.43bn$1.11bn$1.50bn$1.50bn$2.29bn$2.09bn
Capital spending−$403.9m−$340.0m−$272.0m−$268.0m−$283.0m−$309.0m−$278.0m−$235.0m−$336.0m−$291.0m
Free cash flow$974.8m$1.26bn$760.0m−$996.0m$1.14bn$802.0m$1.22bn$1.27bn$1.95bn$1.80bn

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
Revenue$2.78bn$2.48bn$2.84bn$912.0m$2.53bn$2.26bn$2.56bn$2.51bn
Operating income$755.0m$512.5m$730.1m$619.0m$444.0m$276.0m$558.0m$318.0m
Net income$251.3m−$1.40bn−$113.7m$179.0m$148.0m−$58.0m$93.0m−$85.0m
Diluted earnings per share0.66-3.70-0.310.480.40-0.160.25-0.23
Cash from operations$670.0m$230.0m$495.0m$405.0m$289.0m$211.0m$601.0m$405.0m
Capital spending−$77.0m−$147.0m−$93.0m−$91.0m−$100.0m−$124.0m−$107.0m−$71.0m
Free cash flow$593.0m$83.0m$402.0m$314.0m$189.0m$87.0m$494.0m$334.0m
Total assets$24.79bn$24.50bn$26.32bn$26.80bn$27.27bn$26.42bn$26.52bn$26.54bn
Cash and short-term investments$1.82bn$1.30bn$1.32bn$1.34bn$1.73bn$1.13bn$1.18bn$719.0m
Debt$20.76bn$20.77bn$20.91bn$21.04bn$21.74bn$21.51bn$21.62bn$21.51bn
Shareholders' equity−$1.77bn−$2.06bn−$553.0m−$564.4m−$764.0m−$1.18bn−$1.28bn−$1.17bn

Financial ratios

Data as of 29 Oct 2026

FY2025FY2024FY2023FY2022FY2021FY2020
Operating margin21.3%16.2%10.7%18.3%20.3%7.5%
Net margin1.5%-0.5%-6.8%-2.6%-11.1%-7.0%
Return on equity-28.9%3.6%57.9%30.6%884.0%-104.5%
Return on assets0.6%-0.2%-2.2%-0.8%-3.2%-1.8%
Free cash flow yield49.8%53.8%38.0%-13.1%48.5%40.9%
Revenue growth8.5%9.9%7.8%-3.7%5.1%-6.7%
Earnings growth-447.3%-92.2%179.2%-77.4%67.6%-68.6%
Current ratio1.47x0.86x1.30x1.08x1.08x1.09x
Debt to equity-37.77x-16.95x-21.97x-30.08x-214.78x47.03x
Equity ratio-2.1%-4.8%-3.7%-2.7%-0.4%1.7%
Interest coverage1.35x1.12x0.71x1.01x1.20x0.39x
R&D as a share of sales6.1%6.4%6.9%6.5%5.5%5.6%
Buybacks as a share of market value0.4%-4.9%2.3%0.3%-1.4%0.1%

Growth per year

Compound annual rate

3 years5 years10 years
Revenue8.7%5.4%-0.1%
Operating income12.1%23.3%2.2%

Average margins

Over each period

1 year3 years5 years10 years
Operating margin17.4%15.7%14.4%6.5%
Net margin0.6%-1.9%-4.1%-8.4%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020
Price to earnings16.1-68.6-4.7-10.6-4.9-6.1
Price to sales0.30.30.30.30.50.4

Dividends and splits

Per share, in the currency the company pays

Paid for 0 years. Last went ex-dividend on 10 Nov 2010.

FY2010FY2009FY2008FY2007FY2006FY2005
Paid in the year1.280.6451.501.501.000.50
  • 2-for-1 split · 5 Oct 2000
  • 2-for-1 split · 10 Jan 2000
  • 3-for-1 split · 8 Jan 1996

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.